MEDIFAST INC Annual Deferred Income Tax Expense (Benefit) in USD from 2010 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Medifast Inc annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
- Medifast Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $112K, a 86% decline year-over-year.
- Medifast Inc annual Deferred Income Tax Expense (Benefit) for 2024 was -$7.4M, a 711% decline from 2023.
- Medifast Inc annual Deferred Income Tax Expense (Benefit) for 2023 was $1.21M.
- Medifast Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$924K, a 75.1% increase from 2021.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)